Literature DB >> 19917115

Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis.

Manuel García Manero1, Begoña Olartecoechea, Pedro Royo, Juan Luis Alcázar.   

Abstract

OBJECTIVE: Thrombospondin-1 serum levels is correlate with pelvic pain in patients with ovarian endometriosis. PATIENTS: Thrombospondin-1 serum levels were prospectively analysed in 51 patients (group A asymptomatic patients or patients presenting mild dysmenorrhea and women comprised group B severe dysmenorrhea and/or chronic pelvic pain and/or dyspareunia) who underwent surgery for cystic ovarian endometriosis to asses whether a correlation exists among thrombospondin-1 serum levels and pelvic pain.
RESULTS: From 56 patients, five cases were ultimately excluded, because the histological diagnosis was other than cystic ovarian endometriosis (2 teratomas and 3 haemorrhagic cysts). The mean thrombospondin-1 serum levels in group A was 256,69 pg/ml_+37,07 and in group B was 291,41 pg/ml + 35,59.
CONCLUSION: Pain symptoms in ovarian endometriosis is not correlated with thrombospondin-1 serum levels.

Entities:  

Year:  2009        PMID: 19917115      PMCID: PMC2785805          DOI: 10.1186/1757-2215-2-18

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  22 in total

Review 1.  Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities.

Authors:  M Nisolle; J Donnez
Journal:  Fertil Steril       Date:  1997-10       Impact factor: 7.329

2.  High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata.

Authors:  A Fasciani; G D'Ambrogio; G Bocci; M Monti; A R Genazzani; P G Artini
Journal:  Mol Hum Reprod       Date:  2000-01       Impact factor: 4.025

3.  Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis.

Authors:  J McLaren; A Prentice; D S Charnock-Jones; S K Smith
Journal:  Hum Reprod       Date:  1996-01       Impact factor: 6.918

Review 4.  Angiogenic factors in endometriosis.

Authors:  Robert N Taylor; Dan I Lebovic; Michael D Mueller
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

Review 5.  Angiogenesis: a new theory for endometriosis.

Authors:  D L Healy; P A Rogers; L Hii; M Wingfield
Journal:  Hum Reprod Update       Date:  1998 Sep-Oct       Impact factor: 15.610

6.  Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction.

Authors:  R A Ferriani; D S Charnock-Jones; A Prentice; E J Thomas; S K Smith
Journal:  Hum Reprod       Date:  1993-01       Impact factor: 6.918

7.  Angiogenesis in endometriosis.

Authors:  S Matsuzaki; M Canis; C Darcha; P Dechelotte; J L Pouly; M A Bruhat
Journal:  Gynecol Obstet Invest       Date:  1998-08       Impact factor: 2.031

8.  Vascular endothelial growth factor (VEGF) in endometriosis.

Authors:  J Donnez; P Smoes; S Gillerot; F Casanas-Roux; M Nisolle
Journal:  Hum Reprod       Date:  1998-06       Impact factor: 6.918

9.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Serum interleukin-8 levels are elevated in patients with ovarian endometrioma.

Authors:  Yorie Ohata; Tasuku Harada; Hiroko Miyakoda; Fuminori Taniguchi; Tomio Iwabe; Naoki Terakawa
Journal:  Fertil Steril       Date:  2008-07-16       Impact factor: 7.329

View more
  1 in total

Review 1.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.